INNOVATE BIOPHARMACEUTICALS, INC. Note Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to the Amended and Restated Senior Secured Convertible Note Due 2025
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2023
Form of Amended and Restated Senior Secured Convertible Note
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2022
Form of Senior Secured Convertible Note
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2022
Note Purchase Agreement, dated January 10, 2020, by and between the Company and Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2020
Note issued to Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2020
Note Purchase Agreement, dated March 8, 2019, by and between the Company and Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2019
Note issued to Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2019
Option to Purchase Senior Convertible Note, by and between the Company and Gustavia Capital Partners LLC and/or its affiliates dated as of January 7, 2019
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Senior Convertible Note with Gustavia Capital Partners LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
Senior Note dated January 29, 2018
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018